Sensus Healthcare, Inc. (SRTS): Price and Financial Metrics
Sensus Healthcare, Inc. (SRTS)
Today's Latest Price: $3.65 USD
Updated Dec 3 12:56pm
Add SRTS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 143 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
SRTS Stock Summary
- The price/operating cash flow metric for Sensus Healthcare Inc is higher than 97.06% of stocks in our set with a positive cash flow.
- In terms of twelve month growth in earnings before interest and taxes, Sensus Healthcare Inc is reporting a growth rate of 157.77%; that's higher than 91.72% of US stocks.
- As for revenue growth, note that SRTS's revenue has grown -51.59% over the past 12 months; that beats the revenue growth of just 4.77% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Sensus Healthcare Inc are WTT, FEIM, XONE, QUMU, and SONM.
- Visit SRTS's SEC page to see the company's official filings. To visit the company's web site, go to www.sensushealthcare.com.
SRTS Stock Price Chart Interactive Chart >
SRTS Price/Volume Stats
| Current price | $3.65 | 52-week high | $4.99 |
| Prev. close | $3.46 | 52-week low | $1.76 |
| Day low | $3.42 | Volume | 20,872 |
| Day high | $3.73 | Avg. volume | 27,216 |
| 50-day MA | $2.72 | Dividend yield | N/A |
| 200-day MA | $2.78 | Market Cap | 60.23M |
Sensus Healthcare, Inc. (SRTS) Company Bio
Sensus Healthcare, Inc. manufactures and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides Sentinel service program, which offers its customers protection for their SRT-100 and SRT-100 Vision systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was founded in 2010 and is based in Boca Raton, Florida.
SRTS Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $3.65 | $0 | -100% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Sensus Healthcare Inc. To summarize, we found that Sensus Healthcare Inc ranked in the 0th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 100%. The most interesting components of our discounted cash flow analysis for Sensus Healthcare Inc ended up being:
- The company's debt burden, as measured by earnings divided by interest payments, is -399.33; that's higher than only 1.44% of US stocks in the Healthcare sector that have positive free cash flow.
- Its compound free cash flow growth rate, as measured over the past 0.5 years, is -1% -- higher than only 0% of stocks in our DCF forecasting set.
- The business' balance sheet reveals debt to be 4% of the company's capital (with equity being the remaining amount). Approximately only 13.4% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -100% |
| 1% | -100% |
| 2% | -100% |
| 3% | -100% |
| 4% | -100% |
| 5% | -100% |
AGHC, ALC, AMRN, ATRS, and MOR can be thought of as valuation peers to SRTS, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...